Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERASE: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis
NCT06093191Phase 4Completed
- Start
- Oct 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tobramycin in bronchiectasis, Pseudomonas aeruginosa infection. Started Oct 2023; status: completed.
02
Drugs
tobramycin
03
Conditions
bronchiectasisPseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT06093191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06093191.